This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Salicylates and gout

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • some drugs have a paradoxical effect on the renal tubular handling of urate, low doses causing retention and high doses uricosuria
    • biphasic response is most readily demonstrated with salicylate
    • salicylates in low dose inhibit the renal tubular secretion of uric acid, whereas in higher doses they inhibit both secretion and reabsorption. With the high doses, interference with reabsorption predominates so that the net effect is uricosuric
    • the hyperuricaemic effect of small doses of salicylates is probably of little practical importance, although of course a careful drug history must always be taken for diagnostic purposes
    • small doses of aspirin (75 mg daily) are given to patients at high cardiovascular risk
      • plasma and urinary levels of salicylate in these subjects must be extremely low and their effect upon uric acid levels has not been documented; it is unlikely to be significant

Reference:

  • (1) Scott JT.Drug-induced gout. Baillière's Clinical Rheumatology 1991;5 (1): 39-60.

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.